Literature DB >> 27892992

Overall Survival in Cancer Drug Trials as a New Surrogate End Point for Overall Survival in the Real World.

Sham Mailankody1, Vinay Prasad2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27892992     DOI： 10.1001/jamaoncol.2016.5296

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  12 in total

Review 1.  Cancer drug development: The missing links.

Authors:  Ajaikumar B Kunnumakkara; Devivasha Bordoloi; Bethsebie Lalduhsaki Sailo; Nand Kishor Roy; Krishan Kumar Thakur; Kishore Banik; Mehdi Shakibaei; Subash C Gupta; Bharat B Aggarwal
Journal:  Exp Biol Med (Maywood)       Date:  2019-04-08

2.  Disparities in Adolescent and Young Adult Sarcoma Survival: Analyses of the Texas Cancer Registry and the National SEER Data.

Authors:  Jaqueline C Avila; J Andrew Livingston; Ana M Rodriguez; Anne C Kirchhoff; Yong-Fang Kuo; Sapna Kaul
Journal:  J Adolesc Young Adult Oncol       Date:  2018-08-10       Impact factor: 2.223

3.  Real-World Evidence in Oncology: Opportunities and Limitations.

Authors:  Massimo Di Maio; Francesco Perrone; Pierfranco Conte
Journal:  Oncologist       Date:  2019-12-24

Review 4.  The high price of anticancer drugs: origins, implications, barriers, solutions.

Authors:  Vinay Prasad; Kevin De Jesús; Sham Mailankody
Journal:  Nat Rev Clin Oncol       Date:  2017-03-14       Impact factor: 66.675

5.  Liver cancer: Regorafenib as second-line therapy in hepatocellular carcinoma.

Authors:  Austin G Duffy; Tim F Greten
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-02-08       Impact factor: 46.802

6.  Real world data on IO-based therapy for metastatic renal cell carcinoma.

Authors:  Viktoria Stühler; Lisa Herrmann; Steffen Rausch; Arnulf Stenzl; Jens Bedke
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-30       Impact factor: 4.322

Review 7.  Decision Making in Older Adults With Cancer.

Authors:  Clark DuMontier; Kah Poh Loh; Enrique Soto-Perez-de-Celis; William Dale
Journal:  J Clin Oncol       Date:  2021-05-27       Impact factor: 50.717

8.  Use of targeted therapies for advanced renal cell carcinoma in the Veterans Health Administration.

Authors:  Sherrie L Aspinall; Xinhua Zhao; Mark C Geraci; Chester B Good; Francesca E Cunningham; Bernadette B Heron; Daniel Becker; Steve Lee; Vinay Prasad
Journal:  Cancer Med       Date:  2019-09-19       Impact factor: 4.452

9.  Cancer treatment in the last 6 months of life: when inaction can outperform action.

Authors:  Bishal Gyawali; Saroj Niraula
Journal:  Ecancermedicalscience       Date:  2018-04-18

10.  Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma.

Authors:  Kalijn Fredrike Bol; Eva Ellebaek; Lise Hoejberg; Mette Marie Bagger; Mathilde Skaarup Larsen; Tobias Wirenfeldt Klausen; Ulrich Heide Køhler; Henrik Schmidt; Lars Bastholt; Jens Folke Kiilgaard; Marco Donia; Inge Marie Svane
Journal:  Cancers (Basel)       Date:  2019-10-03       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.